Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Journal of the American Society of Nephrology : CJASN|November 13, 2010
Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAsChaim Charytan
Renal Failure|September 25, 2013
Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidismFarhanah Yousaf, Chaim Charytan
Kidney International. Supplement|October 9, 2003
Controversies in iron managementAllen R Nissenson, Chaim Charytan
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|July 31, 2007
The safety of intravenous iron sucrose use in the elderly patientJohn Reed, Chaim Charytan, Jerry Yee
Nephron. Clinical Practice|April 13, 2005
Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysisChaim Charytan, Wajeh Qunibi, George R Bailie, et al.
Case Reports in Medicine|March 8, 2017
Pernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the LiteratureFarhanah Yousaf, Bruce Spinowitz, Chaim Charytan, et al.
Renal Failure|August 11, 2015
Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination seriesFarhanah Yousaf, Sherleen Gandham, Marilyn Galler, et al.
Nephron. Clinical Practice|February 28, 2004
Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron productsChaim Charytan, Michael H Schwenk, Mourhege M Al-Saloum, et al.
Artificial Organs|June 5, 2003
Prediction of single-pool Kt/v based on clinical and hemodialysis variables using multilinear regression, tree-based modeling, and artificial neural networksAlexander Goldfarb-Rumyantzev, Michael H Schwenk, Samuel Liu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2012
Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center studyChaim Charytan, Marializa V Bernardo, Todd A Koch, et al.
Pageof 3